Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapie…
$1.15-2.54%
报价 2026-11-16
市值
$36.4M
EV
$69.8M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -85.1%
$1.15$7.70
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ALPSAlps Group Inc | $36.4M | -2.5% | – | 38.6% | – | – | – | |
| IRLAIRulya Therapeutics Inc. | $38M | -6.1% | – | 0% | – | – | – | |
| BMEABiomea Fusion, Inc. | $37.8M | -10.7% | +20.0% | 0% | – | – | – | |
| EXOZeXoZymes, Inc. | $37M | +4.2% | – | 0% | – | – | – | |
| ELUTElutia Inc. | $36.4M | +0.4% | -36.5% | 59% | 0.7x | – | – | |
| IMAImageneBio Inc | $36.3M | -7.8% | 0.0% | 0% | – | – | – | |
| VERUVeru Inc. | $35.5M | -0.5% | +48.1% | 0% | – | – | – | |
| TELOTelomir Pharmaceuticals, Inc. Common Stock | $35.4M | -2.0% | -99.9% | 0% | – | – | – | |
| RANIRani Therapeutics Holdings, Inc. | $35.3M | +2.7% | -13.5% | 96.7% | – | – | – | |
| 同行中位数 | – | – | -6.7% | 0% | 0.7x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。